ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2026
Thyroxine Disrupts Synaptic Plasticity via Non-genomic Action in the Hippocampus.
Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Numerous neurological deficiency disorders are caused by the thyroid hormones' early-life modulatory actions, which persist throughout adulthood. Pairing-pulse facilitation is used to assess hippocampal short-term plasticity, while long-term potentiation (LTP) is used to assess long-term plasticity. Thyroid hormones target the genes that cause synaptic plasticity to occur. This study focused on the non-genomic effects of T4 hormone in the hippocampus. Methods: After a 15-minute baseline recording, LTP was induced by applying high-frequency stimulation protocols. Infusions of artificial cerebrospinal fluid (aCSF) or L-thyroxine were performed during the stimulation protocols. We performed real-time quantitative polymerase chain reaction (RT-qPCR) to determine whether there was a difference in gene expression levels in the hippocampi of rats infuse with aCSF or T4 and how this correlated with LTP responses. Results: T4 infusion was observed to impair LTP. T4 increased CREB and GluN2B expression in all groups while decreasing GluN1 expression in unstimulated hippocampi and increasing it during the induction phase of LTP. It decreased GluN2A expression during the induction phase of LTP. During the maintenance phase of LTP, T4 prevented the increase in Elk-1 and p38MAPK expression levels observed in the aCSF group. Conclusion: When we evaluated LTP responses together with RT-qPCR analyses, we found that T4 impaired LTP responses and increased CREB and GluN2B expression. T4's reduction of GluN2A expression levels may be responsible for the impairment during the induction phase of LTP, while its inhibition of the increase in Elk-1 expression may be responsible for the impairment observed during the maintenance phase of LTP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.